Announcement
Announcement Under Regulation 30 22 Sep - Jodhpur GST appellate order confirms Rs.71.63 lakh tax, Rs.12.66 lakh penalty and interest for FY20; appeal planned.
Source: Bse
Coromandel International Limited (COROMANDEL)
Mid CapChemicals stocks · Mid cap · NSE
Coromandel International Limited is an Indian agri-input company, primarily engaged in the manufacturing and marketing of fertilizers (Nutrients segment) and crop protection chemicals (CPC segment). It also offers specialty nutrients and organic fertilizers, serving the agricultural sector across India.
Data qualityFresh enough for analysisQuote updated 21 Oct, 02:02 pm ISTDetails
Quote21 Oct, 02:02 pm IST
Base fundamentals16 Oct 2026 · screener
Latest result23 Jul, 07:59 pm IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags15 Aug 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Chemicals P/E 33.1 (n=45)
Technical timing lens
Trend score and candlestick chart
34Bearishfull bear SMA stack · SMA20 -6.9% / mo · MACD + · near 52W low · sector -4.2pp vs Nifty 500 (3M)
Stock trend: 26
Sector RS: 46
Sector 3M: -9.8% vs Nifty 500 -5.6%
Chemicals FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
COROMANDELD candles · FIT view-12.0%TODAY · PROVISIONALLatest price ₹1769.80 on 2026-10-21
Today's candle is provisional from the latest intraday quote; completed-candle scans remain unchanged.
Bar
+0.6%
RSI
43
MACD hist
6.94
52W pos
14%
2026-10-21O ₹1759.90H ₹1784.50L ₹1746.00C ₹1769.80Vol 1.1L shIntraday candle
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
COROMANDELNifty ChemicalsNifty 500
- COROMANDEL
- -12.3%
- Nifty 500
- -5.6%
- Nifty Chemicals
- -8.5%
- Vs Nifty 500
- -6.8 pp
Chart stats
19 Oct 2026- From 52W high
- -29.1%
- 52W range position
- 14%
- ATR (14)
- 3.0%
- Volume vs 20D
- 0.44x
- Avg traded value
- ₹37.4 Cr
- 20D price channel
- ₹1,651.1 - ₹1,990
₹2,499
₹1,651.1 - ₹2,499
₹53.9
Latest completed session
20-session average
34.8% annualized volatility
Research snapshot
What the evidence says now
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is weak.
Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · WATCHLIST43
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Bad2
Revenue +15.9% · PAT -23.9% YoY
Technical
Bearish34
Price trend and sector-relative-strength timing.
Valuation
Legacy model-45.7%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence75
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Bad · 2/100PAT -24% YoY · margin compression · Rev +16% YoY · +36% QoQ
Filed 23 Jul 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹8,165 Cr | +15.9% | +36.0% |
| EBITDA | ₹756 Cr | -3.3% | +54.9% |
| Operating margin | 9.0% | -200 bps | +100 bps |
| PAT | ₹382 Cr | -23.9% | +232.2% |
| PAT margin | 4.7% | -245 bps | +276 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 27.90
- P/B
- 4.14
- EV/EBITDA
- 14.08
- Market Cap
- 52079.00Cr
Profitability
- ROE
- 16.40%
- ROCE
- 22.00%
- ROA
- 7.27%
- Dividend Y
- 0.62%
Growth (CAGR)
- Revenue 5Y
- 17.00%
- EPS 5Y
- 8.00%
- Revenue 3Y
- 2.00%
- EPS 3Y
- -1.00%
Balance Sheet
- Debt/Equity
- 0.12
- Interest Coverage
- 8.76×
- Altman Z
- 5.29
- Book Value
- 426.00
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 6/5
- OCF
- 1558.00 Cr
- EPS TTM
- 62.11
Shareholding
- Promoter Hold
- 56.35%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 13%
Financial History
Updated 20/10/2026
Revenue
₹ CrLatest: 24.1k+9.2% vs prev
Net Profit
₹ CrLatest: 1,778-6.3% vs prev
Return on Equity
%Latest: 16.0-20.4% vs prev
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Mixed signalsSignals are conflicting — long-term trend down. RSI 43. Wait for confirmation.
- Price < SMA20 < SMA50 < SMA200 — full bearish stack.
- SMA20 falling (~7.8% over last month) — short-term momentum negative.
- RSI(14) at 43 — rising, no extreme reading.
- MACD above signal, histogram expanding — bullish momentum building.
- 29% off 52W high · 7% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
28
RS percentile
Stage 4 Downtrend
1M return
-11.4%
3M return
-12.3%
6M return
-12.9%
1Y return
-21.0%
RS 1D
+5
RS 20D
-6
Sector rank
#13
Industry rank
-
Stage evidence
- Price is 9.2% below the 30-week proxy.
- The 50-DMA is below the 30-week proxy and its slope is falling -2.1%.
- Both 3-month and 6-month returns are negative.
50-DMA
price below
200-DMA
price below
Sector
neutral
Industry
unranked
Relative-strength line vs Nifty 500 (base 100)
261 observations
19 Oct 2026Value 81.62+1.75%
RS vs Nifty 50082
Valuation & peers
U-Score 43 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
Valuation & peers
U-Score 43 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
WATCHLIST
Fundamental score breakdown
U band · WATCHLISTValuation3/30
Growth9/25
Quality12/20
Balance Sheet9/15
Cash Flow4/10
Piotroski
8/9 (+5)
Penalties
1
Raw sum
43
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
43/100 · legacy band WATCHLIST
Positive drivers
- Piotroski is strong at 8/9.
- Quality contributes 12/20 to the score.
- Balance sheet contributes 9/15 to the score.
Main drags
- Fair-value margin of safety is negative at -45.7%.
- Valuation is weaker at 3/30; verify the latest quarterly trend.
- Growth is weaker at 9/25; verify the latest quarterly trend.
Sector valuation model
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
27.9
PB
4.1
EV/EBITDA
14.1
ROE
16.4%
ROCE
22.0%
FCF Yield
—
Debt/Equity
0.1
MoS
-45.7%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
43
Previous: 43
Legacy U-Score band
WATCHLIST
Previous: WATCHLIST
Margin of safety
-45.7%
Previous: -45.9%
Score history
12 stored score snapshots. Latest stored move: +0 points.
21 Oct 2026
v4.3-runtime-valuation
42
42
42
42
42
42
43
43
43
43
43
43
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹771.57
-129.4% MoS
Growth-justified P/E
19.6
Growth-justified Value
₹1,214.25
-45.7% MoS
PEG
3.49
Comparable companies
Peers
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
SUMICHEM
Large
Sumitomo Chemical India Limited
Fertilizers & Agrochemicals
match 152
44
35.3
16.2%
-73%
WATCHLIST
KANSAINER
Micro
Kansai Nerolac Paints Limited
Fertilizers & Agrochemicals
match 150
38
22.5
8.8%
-176%
WATCHLIST
PCBL
Large
PCBL Chemical Limited
Fertilizers & Agrochemicals
match 149
28
45.0
5.6%
-906%
OVERVALUED
PRIVISCL
Micro
Privi Speciality Chemicals Limited
Fertilizers & Agrochemicals
match 149
66
38.0
26.0%
+18%
UNDERVALUED
SUDARSCHEM
Micro
Sudarshan Chemical Industries Limited
Fertilizers & Agrochemicals
match 148
24
89.6
0.5%
-8507%
OVERVALUED
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Where growth can come from, and what can break the case
Thesis under stressReviewed 2026-06-03T19:11:30.607Z
Management commentary snapshot
Q4 FY26 consolidated revenue grew 20% YoY to ₹6,004 Cr, but PAT plunged 80% YoY to ₹115 Cr due to a sharp decline in Nutrients segment PBIT and exceptional items. Full-year FY26 revenue rose 31% YoY to ₹31,480 Cr, while PAT declined 8% YoY to ₹1,898 Cr.
While full-year revenue growth was strong, the significant Q4 PAT decline and overall margin contraction (EBITDA and PAT) raise concerns. The Nutrients segment's Q4 PBIT drop is a key issue, partially offset by strong performance in the CPC segment, boosted by an acquisition. Exceptional items also impacted Q4.
Growth engines
CPC Segment Growth
Consolidated CPC revenue grew 50% YoY in FY26 and 54% YoY in Q4 FY26, with PBIT up 41% and 19% respectively.
Urea Sales Volume
Urea sales volume increased 66.6% YoY in FY26 and 42.8% YoY in Q4 FY26 for the Nutrients segment.
Imported NPK+DAP Sales Volume
Imported NPK+DAP sales volume grew 54.8% YoY in FY26 and 26.1% YoY in Q4 FY26.
Capacity and execution
NACL Industries Acquisition
NACL Industries Limited became a subsidiary of Coromandel effective August 8, 2025, contributing to consolidated CPC segment growth.
Headwinds
Exceptional Items
The company reported -₹71 Cr in exceptional items in Q4 FY26 and FY26, impacting PAT.
Nutrients Segment PBIT Decline (Q4)
Nutrients segment PBIT declined 18% YoY in Q4 FY26, despite a 15% increase in sales.
Overall Margin Contraction
Consolidated EBITDA margin decreased from 9% to 8% in Q4 FY26 and from 11% to 10% in FY26. PAT margin also declined.
Management accountability
What management said, and what results must prove
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Analyst reading lens
Compare BOTH
Both quarterly (Q4) and annual (FY) comparisons are essential. Q4 shows recent momentum and specific challenges (e.g., Nutrients PBIT drop, exceptional items), while FY provides a broader view of annual performance and strategic impact (e.g., NACL acquisition).
Sector KPIs management disclosed
Revenue from Operations (Consolidated)
Q4 FY26: ₹6,004 Cr (+20% YoY); FY26: ₹31,480 Cr (+31% YoY).
EBITDA (Consolidated)
Q4 FY26: ₹494 Cr (+16% YoY); FY26: ₹3,232 Cr (+23% YoY).
PAT (Consolidated)
Q4 FY26: ₹115 Cr (-80% YoY); FY26: ₹1,898 Cr (-8% YoY).
EBITDA Margin (Consolidated)
Q4 FY26: 8% (vs 9% Q4 FY25); FY26: 10% (vs 11% FY25).
Thesis monitor
Numbers and claims to verify in the next filings
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Nutrients Segment PBIT Trend | Q4 FY26 PBIT down 18% YoY. | Reversal of PBIT decline and margin improvement in the Nutrients segment. |
| Consolidated Margin Trend | FY26 EBITDA margin 10% (vs 11% FY25), PAT margin 6% (vs 9% FY25). | Stabilization and expansion of consolidated EBITDA and PAT margins. |
| Integration of NACL Industries | NACL became a subsidiary in August 2025, boosting CPC segment. | Continued strong performance and synergy realization from the acquired entity. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust Score
75Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 78th percentile of the scored universe and 64th percentile within Chemicals. Main check: results consistency is weak at 54/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 21 Oct 2026
management-trust-v1
76 docs text-extracted · 37 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
78th percentile
overall median 67 · Chemicals: 64th pctile, median 73 · Mid: 48th pctile, median 76
Evidence depth
Financial-only
76 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
86
strong · holding, pledge, alignment
Cash flow
67
acceptable · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
74
acceptable · capital discipline
Results
54
watch · quarterly consistency
Trust positives
- ▸Promoter holding is 56.4%.
- ▸Promoter pledge is zero.
- ▸6 years of positive FCF.
- ▸ROCE is 22%.
Trust risks
- ▸1/4 latest quarters had positive YoY PAT growth.
- ▸1 of the latest 4 quarters had PAT decline worse than 25% YoY.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Coromandel International Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Announcement
Announcement Under Regulation 30 2 Sep - Coromandel converts Rs 108.07 crore loan to equity in wholly owned subsidiary Coromandel Chemicals Limited.
Source: Bse
Announcement
Announcement Under Regulation 30 21 Aug - Jammu GST appellate order confirms ₹1.23 crore tax, ₹12.35 lakh penalty for FY19; company will appeal.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 21 Aug
Source: Bse
Investor presentation
Announcement under Regulation 30 (LODR)-Investor Presentation 24 Jul
Source: Bse
Annual report
Annual Report 2026
Source: Bse
Annual report
Annual Report 2025
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.